After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. The current market capitalization of Thermo Fisher Scientific Inc is $220.35B. A total of 1.37 million shares were traded on the day, compared to an average of 2.06M shares.
In the most recent transaction, Britt Lisa P. sold 10,225 shares of TMO for 571.62 per share on Nov 07 ’25. After the transaction, the Sr. VP and Chief HR Officer now owns 14,145 company shares. In a previous transaction on Nov 10 ’25, Pettiti Gianluca bought 2,975 shares at 580.00 per share.
Among the insiders who bought shares, Britt Lisa P. acquired of 10,225 shares on Nov 07 ’25 at a per-share price of $571.62. In another insider transaction, Pettiti Gianluca sold 400 shares at $574.15 per share on Oct 24 ’25. Company shares held by the Executive Vice President now total 21,152.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Thermo Fisher Scientific Inc pays an annual dividend of $1.68, resulting in a dividend yield of 0.29%, and it has a price to earnings (P/E) ratio of 33.89.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TMO has a high of $610.97 and a low of $385.46.
As of this writing, TMO has an earnings estimate of $6.45 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $6.52 per share and a lower estimate of $6.39. The company reported an EPS of $6.1 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TMO’s latest balance sheet shows that the firm has $4.48B in Cash & Short Term Investments as of fiscal 2021. There were $34.87B in debt and $13.44B in liabilities at the time. Its Book Value Per Share was $135.79, while its Total Shareholder’s Equity was $40.98B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Buy with a score of 4.48.
